Clinical Trials · NCT01606072
Perioperative Use of Desmopressin (DDAVP) in Breast Cancer
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Enrollment
- 21
- Start date
- Nov 2011
- Locations
- 1 site, Argentina
- Primary endpoint
- Selection of the higher safe dose level for ensuing clinical trials